Hospital Universitario Ramón y Cajal, Madrid, Spain.
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics-European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as 'presarcopenia', 'sarcopenia' and 'severe sarcopenia'. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
欧洲老年人肌肉减少症工作组(EWGSOP)制定了一个实用的临床定义和共识诊断标准,用于诊断与年龄相关的肌肉减少症。EWGSOP 包括来自四个参与组织的代表,即欧洲老年医学学会、欧洲临床营养与代谢学会、国际老年学和老年医学协会-欧洲区域以及国际营养与老龄化协会。这些组织认可了最终文件中的发现。该小组开会并解决了以下问题,利用医学文献构建基于证据的答案:(i)什么是肌肉减少症?(ii)哪些参数定义了肌肉减少症?(iii)哪些变量反映了这些参数,以及可以使用哪些测量工具和截止点?(iv)肌肉减少症与恶病质、虚弱和肌肉减少性肥胖有何关系?对于肌肉减少症的诊断,EWGSOP 建议同时使用低肌肉量+低肌肉功能(力量或表现)来诊断。EWGSOP 将这些特征应用于进一步定义概念阶段,如“前肌肉减少症”、“肌肉减少症”和“严重肌肉减少症”。EWGSOP 审查了广泛的工具,这些工具可用于测量肌肉量、肌肉力量和身体机能的特定变量。我们的论文总结了目前可用于根据年龄和性别定义肌肉减少症截止点的数据;建议了一种基于步态速度、握力和肌肉量测量的老年人肌肉减少症病例发现算法;并列出了建议的研究主要和次要结果领域。一旦采用了肌肉减少症的操作性定义并将其纳入全面老年评估的主流,下一步就是定义肌肉减少症的自然病程,并开发和定义有效的治疗方法。